Profile
DHR-PA DHR-PB TMO DHR IDXX A
Company Name Danaher Corporation Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IDEXX Laboratories, Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap - $916.76B $155.57B $143.61B $42.73B $33.26B
Employees 78.00K 79.00K 125.00K 61.00K 11.00K 17.90K
CEO - Rainer M. Blair Marc N. Casper Mr. Rainer M. Blair Jonathan J. Mazelsky Mr. Padraig McDonnell
Ratings
DHR-PA DHR-PB TMO DHR IDXX A
Quant Rating Score 3 5 3 3 3 3
Quant Rating Neutral Strong Buy Neutral Neutral Neutral Neutral
Trading
DHR-PA DHR-PB TMO DHR IDXX A
Last Close $1841.01 $1261.26 $408.28 $198.8 $531.32 $119.17
High 52 $1841.01 $1261.26 $624.21 $280.76 $531.32 $152.6
Low 52 $1841.01 $1261.26 $390.2 $174.64 $361.04 $99.29
Price vs. 52 Week High 0 % 0 % -34.59 % -29.19 % 0 % -21.91 %
Price vs. 52 Week Low 0 % 0 % 4.63 % 13.83 % 47.16 % 20.02 %
Total Return
DHR-PA DHR-PB TMO DHR IDXX A
1 Month Return 0 % 0 % 1.39 % 4.69 % 3.5 % 6.48 %
3 Month Return 0 % 0 % -18.37 % -3.42 % 27.76 % 2.13 %
6 Month Return 0 % 0 % -21.31 % -13.43 % 28.73 % -11.35 %
9 Month Return 0 % 0 % -34 % -28.49 % 5.17 % -19.74 %
YTD Return 0 % 0 % -21.52 % -13.4 % 28.51 % -11.29 %
1 Year Return 0 % 0 % -26.17 % -20.43 % 9.06 % -8.07 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
DHR-PA DHR-PB TMO DHR IDXX A
Dividend Yield Percentage (TTM) 0.58 % 0.59 % 0.4 % 0.56 % - 0.83 %
Dividend Paid and Capex Coverage Ration (TTM) 2.93 % 2.93 % 4.05 % 2.93 % 7.41 % 3.43 %
Dividend Per Share (TTM) 1.13 % 1.18 % 1.64 % 1.13 % - 0.97 %
Payout Ratio (TTM) 20.85 % 20.85 % 9.16 % 20.85 % - 23.76 %
Profitability
DHR-PA DHR-PB TMO DHR IDXX A
Gross Profit Margin TTM 59.74 % 59.74 % 41.57 % 59.74 % 61.32 % 53.79 %
Return on Assets TTM 4.76 % 4.76 % 6.58 % 4.76 % 27.85 % 9.59 %
Return on Equity TTM 7.47 % 7.47 % 13.34 % 7.47 % 57.35 % 19.46 %
Return on Capital Employed TTM 6.66 % 6.66 % 8.53 % 6.66 % 55.24 % 13.97 %
Net Income Per EBT TTM 83.59 % 83.59 % 92.18 % 83.59 % 79.59 % 85.05 %
EBT Per Ebit TTM 93.35 % 93.35 % 96.45 % 93.35 % 97.98 % 96.75 %
EBIT Per Revenue TTM 20.26 % 20.26 % 17.08 % 20.26 % 29.19 % 21.38 %
Cash Flow To Debt Ratio TTM 37.92 % 37.92 % 23.81 % 37.92 % 91.41 % 45.35 %
Receivables Turnover TTM 6.79 6.79 5.07 6.79 6.51 4.85
Payables Turnover TTM 5.57 5.57 - 5.57 12.66 5.94
Inventory Turnover TTM 3.79 3.79 4.8 3.79 3.84 3.1
Fixed Asset Turnover TTM 466.14 % 466.14 % 459.74 % 466.14 % 471.66 % 346.65 %
Asset Turnover TTM 30.11 % 30.11 % 43.31 % 30.11 % 122.35 % 54.52 %
Operating Cash Flow Per Share TTM 8.72 8.72 21.53 8.72 11.91 5.56
Free Cash Flow Per Share TTM 6.84 6.84 17.79 6.84 10.3 4.91
Cash Per Share TTM 278.24 % 278.24 % 1573.28 % 278.24 % 201.64 % 521.4 %
Operating Cash Flow Sales Ratio TTM 26.23 % 26.23 % 18.97 % 26.23 % 24.63 % 23.91 %
Free Cash Flow Operating Cash Flow Ratio TTM 78.46 % 78.46 % 82.61 % 78.46 % 86.51 % 88.33 %
Cash Flow Coverage Ratios TTM 37.92 % 37.92 % 23.81 % 37.92 % 91.41 % 45.35 %
Price To Free Cash Flows Ratio TTM 28.39 29.02 23.14 29.3 51.01 23.76
Price To Operating Cash Flows Ratio TTM 22.29 22.79 19.14 23.01 44.62 21.05
Price Cash Flow Ratio TTM 22.29 22.79 19.14 23.01 44.62 21.05
Income Statement (TTM)
DHR-PA DHR-PB TMO DHR IDXX A
Revenue $23.88B $23.88B $42.88B $23.88B $3.9B $6.51B
Gross Profit $14.21B $14.21B $17.7B $14.21B $2.38B $3.54B
Gross Profit Ratio 59.5% 59.5% 41.28% 59.5% 61.04% 54.3%
EBITDA $7.28B $7.28B $11.8B $7.28B $1.28B $1.87B
Net Income $3.9B $3.9B $6.34B $3.9B $0.89B $1.29B
EPS Diluted 5.29 5.29 16.53 5.29 10.67 4.43
Balance Sheet (MRQ)
DHR-PA DHR-PB TMO DHR IDXX A
Long Term Debt $15.5B $15.5B $29.06B $15.5B $0.55B $3.35B
Total Liabilities $27.99B $27.99B $47.65B $27.99B $1.7B $5.95B
Total Equity $49.55B $49.55B $49.67B $49.55B $1.6B $5.9B
Total Investments $0B $0B $1.56B $0B $0.06B $0.18B
Total Debt $16.01B $16.01B $31.28B $16.01B $0.99B $3.39B
Total Assets $77.54B $77.54B $97.32B $77.54B $3.29B $11.85B
Cash Flow Statement (TTM)
DHR-PA DHR-PB TMO DHR IDXX A
Net Income $3.9B $3.9B $6.34B $3.9B $0.89B $1.29B
Inventory $0.15B $0.15B $0B $0.15B $-0.03B $0.03B
Dividends Paid $-0.77B $-0.77B $-0.58B $-0.77B $0B $-0.27B
Operating Cash Flow $6.69B $6.69B $8.67B $6.69B $0.93B $1.75B
Capital Expenditure $-1.39B $-1.39B $-1.4B $-1.39B $-0.13B $-0.38B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 118.08
ACRS Aclaris Therapeutics, Inc. 1.425
ADVB Advanced Biomed Inc. Common Stock 0.6901
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 5.08
AWH Aspira Women's Health Inc. 0.082
BDSX Biodesix, Inc. 0.282
BIAF bioAffinity Technologies, Inc. 0.281
BIAFW bioAffinity Technologies, Inc. 0.13
BIOC Biocept, Inc. 0.4349
BNGO Bionano Genomics, Inc. 3.274
BNR Burning Rock Biotech Limited 3.1772
CDNA CareDx, Inc 19.55
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 0.76
CNTG Centogene N.V. 0.325
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 151.72
CSTL Castle Biosciences, Inc. 20.42
DGX Quest Diagnostics Incorporated 179.66
Unlock